Close

ViroPharma (VPHM), Halozyme (HALO) Given FDA Ok to Resume Cinryze Studies

September 21, 2012 7:02 AM EDT Send to a Friend
ViroPharma Incorporated (Nasdaq: VPHM) and Halozyme Therapeutics, Inc. (Nasdaq: HALO) announced the FDA provided guidance enabling ViroPharma to resume clinical ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login